Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis

Area of Science:

• Cardiology
• Pathology
• Biochemistry

Background:

• AL (light-chain) and AA (serum amyloid-associated) amyloidosis are systemic diseases characterized by amyloid fibril deposition.
• Cardiac involvement is a major determinant of prognosis in both AL and AA amyloidosis.
• While clinically similar, the underlying fibril composition differs between AL and AA amyloidosis.

Purpose of the Study:

• To investigate the role of fibril composition in the clinical presentation of cardiac infiltration in AL and AA amyloidosis.
• To compare the electrocardiographic and echocardiographic features of heart involvement in AL and AA amyloidosis.
• To elucidate how fibril type influences the pattern and significance of cardiac amyloid deposition.

Main Methods:

• Biochemical analysis of amyloid fibril composition from patient samples.
• Histopathological examination and specific staining techniques for amyloid deposits.
• Comprehensive electrocardiographic (ECG) and echocardiographic assessment of cardiac structure and function.

Main Results:

• Amyloid fibrils in AL and AA amyloidosis exhibit distinct biochemical profiles and staining properties despite similar macroscopic appearance.
• Electrocardiographic and echocardiographic findings in cardiac AA amyloidosis mirror those observed in cardiac AL amyloidosis.
• The study identified significant correlations between fibril type and the specific patterns of cardiac infiltration.

Conclusions:

• The biochemical nature of amyloid fibrils is a critical determinant of the clinical manifestations and prognostic implications of cardiac involvement in amyloidosis.
• Despite overlapping echocardiographic and electrocardiographic features, the underlying fibril composition dictates the characteristic cardiac infiltration patterns.
• These findings underscore the importance of identifying fibril type for tailored therapeutic strategies and improved patient outcomes in amyloidosis.